Feride KOÇ, Alptuğ ATİLA, Emre KARAKUŞ, Kamil ÜNEY

Influences of flunixin and tenoxicam on the pharmacokinetics of florfenicol in lipopolysaccharide-induced endotoxemia

The purpose of this study was to investigate the influences of flunixin (FM) and tenoxicam (TN) on the pharmacokinetics of florfenicol (FF) after coadministration in lipopolysaccharide (LPS)-induced endotoxemic rabbits. Fifteen male rabbits were used in this study. FF (20 mg/kg), FM (2 mg/kg), and TN (1 mg/kg) were coadministered via intravenous injection to the animals. The concentrations of FF were determined by high-performance liquid chromatography with diode-array detection from 0.08 to 12 h in plasma. The plasma concentration-time profile of FF was described using a noncompartmental open model. In this study, terminal half-life, area under the curve, mean residence time, and volume of distribution at steady state were significantly increased, whereas total body clearance was decreased in coadministered groups. In conclusion, FM and TN have effects on the pharmacokinetics of FF in coadministered endotoxemic rabbits. When FF is coadministered with FM and TN, it can be given at a dose of 20 mg/kg b.w. every 8 h for treatment of infections caused by susceptible pathogens with a minimum inhibitory concentration (MIC) of = Keywords: Pharmacokinetics, florfenicol, rabbit, flunixin, tenoxicam, lipopolysaccharide Full Text: PDF

Anahtar Kelimeler:

Pharmacokinetics, florfenicol, rabbit, flunixin, tenoxicam, lipopolysaccharide

Influences of flunixin and tenoxicam on the pharmacokinetics of florfenicol in lipopolysaccharide-induced endotoxemia

Keywords:

Pharmacokinetics, florfenicol, rabbit, flunixin, tenoxicam, lipopolysaccharide,

PDF

___

Papich MG, Riviere JE. Chloramphenicol and derivatives, macrolides, lincosamides and miscellaneous antimicrobials. In: Adams HR, editor. Veterinary Pharmacology and Therapeutics. 8th ed. Ames, IA, USA: Iowa State University Press; 2001. pp. 868–897.
Verbeeck RK. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 1990; 19: 44–66.
Li JZ, Fung KF, Chen ZL, Zhang J. Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae. Eur J Drug Metab Pharmacokinet 2002; 27: 265–271.
El-Aty AM, Goudah A, El-Sooud KA, El-Zorba HY, Shimoda M, Zhou HH. Pharmacokinetics and bioavailability of florfenicol following intravenous, intramuscular and oral administrations in rabbits. Vet Res Commun 2004; 28: 515– 524.
Park BK, Lim JH, Kim MS, Hwang YH, Yun HI. Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits. J Vet Pharmacol Ther 2007; 30: 32–36.
Koc F, Ozturk M, Kadioglu Y, Dogan E, Yanmaz LE, Okumus Z. Pharmacokinetics of florfenicol after intravenous and intramuscular administration in New Zealand White rabbits. Res Vet Sci 2009; 87: 102–105.
Koc F, Uney K, Ozturk M, Kadioglu Y, Atila A. Pharmacokinetics and bioavailability of florfenicol in the plasma of Japanese quails. New Zeal Vet J 2009; 57: 388–391.
Atef M, El-Gendi AY, Amer AM, El-Aty AM. Effect of three anthelmentics on disposition kinetics of florfenicol in goats. Food Chem Toxicol 2010; 48: 3340–3344.
Kim EY, Gebru E, Lee JS, Kim JC, Park SC. Pharmacokinetics of a florfenicol-tylosin combination after intravenous and intramuscular administration to beagle dogs. J Vet Med Sci 2011; 73: 463–466.
Wang G, Tu P, Chen X, Guo YG, Jiang SX. Effect of three polyether ionophores on pharmacokinetics of florfenicol in male broilers. J Vet Pharmacol Ther 2013; 36: 494–501.
Koc F, Atila A, Karakus E, Cetin N. Determination of florfenicol in plasma of rabbits by high-performance liquid chromatography after solid phase extraction. J Vet Pharmacol Ther 2012; 35: 89–89.
Turnidge JD. The pharmacodynamics of beta-lactams. Clin Infect Dis 1998; 27: 10–22.
Priebe S, Schwarz S. In vitro activities of florfenicol against bovine and porcine respiratory tract pathogens. Antimicrob Agents Chemother 2003; 47: 2703–2705.
Kehrenberg C, Mumme J, Wallmann J, Verspohl J, Tegeler R, Kühn T, Schwarz S. Monitoring of florfenicol susceptibility among bovine and porcine respiratory tract pathogens collected in Germany during the years 2002 and 2003. J Antimicrob Chemother 2004; 54: 572–574.
Dunn MJ, Hood VL. Prostaglandins and the kidney. Am J Phys Ren Phys 1977; 233: 169–184.
Hasegawa T, Takagi K, Kitaichi K. Effects of bacterial endotoxin on drugs pharmacokinetics. Nagoya J Med Sci 1999; 6: 11–28.
Yang KH, Lee MG. Effects of endotoxin derived from Escherichia coli lipopolysaccharide on the pharmacokinetics of drugs. Arch Pharm Res 2008; 31: 1073–1086.
Liu J, Fung KF, Chen Z, Zeng Z, Zhang J. Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae. Antimicrob Agents Chemother 2003; 47: 820–823.
Shen J, Wu X, Hu D, Jiang H. Pharmacokinetics of florfenicol in healthy and Escherichia coli-infected broiler chickens. Res Vet Sci 2002; 73: 137–140.
AliAbadi FS, Lees P. Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. Int J Antimicrob Agents 2000; 14: 307–313.
Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 1995; 22: 89–96.
McKellar QA, Sanchez Bruni SF, Jones DG. Pharmacokinetic/ pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J Vet Pharm Therap 2004; 27: 503–514.
Toutain PL, Del Castillo JRE, Bousquet-Melou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Res Vet Sci 2002; 73: 105–114.